Patents by Inventor Caty Casas Louzao

Caty Casas Louzao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW COMBINATION THERAPIES FOR TREATING NEUROLOGICAL DAMAGE
    Publication number: 20180311191
    Abstract: The invention is directed to combinations of acamprosate and ribavirin, to pharmaceutical compositions, kits and treatment methods for the treatment or prevention of neurological damage.
    Type: Application
    Filed: October 17, 2016
    Publication date: November 1, 2018
    Applicant: UNIVERSITAT AUTONOMA DE BARCELONA
    Inventors: Caty CASAS LOUZAO, David ROMEO GUITART, Joaquim FORÉS VIÑETA, Mireia COMA, Albert PUJOL, José Manuel MAS
  • Transgenic animals exhibiting major disorders related to Alzheimer's disease
    Patent number: 7700823
    Abstract: The present invention relates to nonhuman transgenic animals exhibiting major disorders related to Alzheimer's disease. The animals can be used for demonstrating compounds intended for the treatment of Alzheimer's disease.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: April 20, 2010
    Assignee: Aventis Pharma S.A.
    Inventors: Caty Casas Louzao, Patrick Benoit, Laurent Pradier, Gunter Tremp, Jean-Michel Itier, Véronique Blanchard-Bregeon
  • Transgenic animals exhibiting major disorders related to Alzheimer's disease
    Publication number: 20050076400
    Abstract: The present invention relates to nonhuman transgenic animals exhibiting major disorders related to Alzheimer's disease. The animals can be used for demonstrating compounds intended for the treatment of Alzheimer's disease.
    Type: Application
    Filed: October 1, 2004
    Publication date: April 7, 2005
    Applicant: Aventis Pharma S. A.
    Inventors: Caty Casas Louzao, Patrick Benoit, Laurent Pradier, Gunter Tremp, Jean-Michel Itier, Veronique Blanchard-Bregeon